ScreenerHero

RWBRed White & Bloom Brands Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · redwhitebloom.com
0.0250CADMkt Cap: 6.85M $P/E: —

Red White & Bloom Brands Inc. manufactures and distributes cannabis products and accessories in the United States, Canada, and internationally. It operates through Distribution, Licensing, and Retail segments. The compan…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.19BUSDP/E 23.7
TAK
Takeda Pharmaceutical Co. Ltd.
$58.06BUSD
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.98BUSDP/E 20.4
TEVA
Teva Pharmaceutical Industries Limited
$43.51BUSDP/E 62.2
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
ZTS
Zoetis Inc.
$32.12BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.01BUSDP/E 18.4
VTRS
Viatris, Inc.
$18.75BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.34BUSDP/E 117.3
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
NBIX
Neurocrine Biosciences, Inc.
$15.51BUSDP/E 22.3
ELAN
Elanco Animal Health Incorporat
$11.98BUSD
RDY
Dr. Reddy's Laboratories Ltd
$10.15BUSDP/E 29.7
KRK
Krka, d. d.
$8.66BUSDP/E 19.0
ALKS
Alkermes plc
$8.11BUSDP/E 127.2
HIMS
Hims & Hers Health, Inc.
$7.88BUSD
LNTH
Lantheus Holdings Inc
$6.53BUSDP/E 23.9
AMRX
Amneal Pharmaceuticals, Inc. Class A
$6.24BUSDP/E 37.3
LQDA
Liquidia Corporation
$6.14BUSDP/E 49.0
KNSA
Kiniksa Pharmaceuticals, Ltd.
$6.08BUSDP/E 79.8

Key Statistics

Company
Market Cap6.85M $
Enterprise Value314.43M $
Revenue (TTM)43.39M $
Gross Profit16.44M $
Net Income (TTM)-49.79M $
Revenue/Share0.0925 USD
Last Price0.0250 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.19
PEG—
EV/EBITDA-55.86
EV/Revenue7.25
P/S0.24
P/B-0.06
EPS (TTM)-0.20
EPS (Forward)-0.16
52W Range
—
52W High0.0200 CAD
52W Low0.0200 CAD
Profitability
Gross Margin34.83%
Oper. Margin-19.35%
EBITDA Margin-12.97%
Profit Margin-105.47%
ROE30.07%
ROA-30.15%
Growth
Revenue Growth-27.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.97M $
CapEx (TTM)2.21M $
FCF Margin-104.93%
FCF Yield-664.22%
Net Debt315.18M $
Net Debt/EBITDA-55.99
Balance Sheet
Debt/Equity-1.85
Current Ratio0.78
Quick Ratio0.11
Book Value/Sh-0.5140 CAD
Cash/Share0.0080 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:16
Split DateJun 5, 2020
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.470.60M
Float439.54M
Insiders7.92%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short99
Short (prev mo.)99
Technical
SMA 500.0232 (+7.8%)
SMA 2000.0255 (-1.9%)
Beta-0.65
S&P 52W Chg18.16%
Avg Vol (30d)27.00K
Avg Vol (10d)34.84K
Technical Indicators
RSI (14)41.6
MACD0.0000
MACD Signal-0.0001
MACD Hist.+0.0001
BB Upper0.0279 CAD
BB Middle0.0227 CAD
BB Lower0.0176 CAD
BB Width44.87%
ATR (14)0.0029 CAD
Vol Ratio (20d)0.59x